Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Tamoxifen Citrate Patent Expiration

Tamoxifen Citrate was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Nolvadex on Approved Prior to Jan 1, 1982. Another drug containing Tamoxifen Citrate is Soltamox. 14 different companies have introduced drugs containing Tamoxifen Citrate.


Tamoxifen Citrate Patents

Given below is the list of patents protecting Tamoxifen Citrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Soltamox US6127425 Oral liquid medicine solution Jun 26, 2018

(Expired)

 Mayne Pharma Commrcl



Tamoxifen Citrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tamoxifen Citrate Generic API Manufacturers

Several generic applications have been filed for Tamoxifen Citrate. The first generic version for Tamoxifen Citrate was by Actavis Laboratories Fl Inc and was approved on Feb 20, 2003. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Aug 14, 2020.

Given below is the list of companies who have filed for Tamoxifen Citrate generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003
EQ 10MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003





2. AEGIS PHARMS

Aegis Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Aegis Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Mar 31, 2003
EQ 20MG BASE

tablet Discontinued ORAL N/A Mar 31, 2003





3. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Discontinued ORAL N/A Sep 23, 2011
EQ 10MG BASE

tablet Discontinued ORAL N/A Sep 23, 2011


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Richmond Hill Apotex Inc.
Etobicoke Apotex, Inc.
Brantford Apotex Pharmachem Inc.
Toronto Apotex Inc.
North York Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





4. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB Feb 20, 2003
EQ 20MG BASE

(reference standard)

tablet Prescription ORAL AB Feb 20, 2003





5. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Prescription ORAL AB Aug 14, 2020
EQ 10MG BASE

tablet Prescription ORAL AB Aug 14, 2020


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





6. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003
EQ 20MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003





7. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Prescription ORAL AB Feb 20, 2003
EQ 10MG BASE

tablet Prescription ORAL AB Feb 20, 2003


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Saint Albans Mylan Technologies, Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
San Carlos Mylan Pharmaceuticals Inc.
Morgantown Mylan Specialty, L.P.
Rockford Mylan Institutional, Inc.
Greensboro Mylan Pharmaceuticals Inc
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
India
Bangalore Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





8. PHARMACHEMIE

Pharmachemie Bv has filed for 1 generic for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Pharmachemie.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Mar 31, 2003


Manufacturing Plant Locations
New

Pharmachemie's manufacturing plants are situated in 1 country - Netherlands. Given below are the details of these plant locations as well as the firm names of Pharmachemie as present at those locations.

Country City Firm Name
Netherlands
Haarlem Pharmachemie B.V. dba Teva Pharmachemie





9. ROXANE

Roxane Laboratories Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003
EQ 20MG BASE

tablet Discontinued ORAL N/A Feb 20, 2003





10. TEVA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Discontinued ORAL N/A Apr 28, 2003
EQ 10MG BASE

tablet Discontinued ORAL N/A Apr 28, 2003


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
India
Bhind Teva API India Ltd- Malanpur
Gajraula, Amroha Teva API India Private Ltd.
Canada
Stouffville Teva Canada Limited
Scarborough Teva Canada Limited
Markham Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





11. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet Prescription ORAL AB Feb 20, 2003





12. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Tamoxifen Citrate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB Oct 27, 2017
EQ 20MG BASE

tablet Prescription ORAL AB Oct 27, 2017